| scholarly article | Q13442814 |
| P2093 | author name string | José-María Sánchez-González | |
| Concepción De-Hita-Cantalejo | |||
| María Carmen Sánchez-González | |||
| P2860 | cites work | Proteomic analysis of human meibomian gland secretions | Q24679524 |
| Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study | Q33280498 | ||
| Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis | Q33553643 | ||
| Meibomian gland studies: comparison of steer and human lipids. | Q34281112 | ||
| A review of meibography. | Q38001319 | ||
| Lipid-containing lubricants for dry eye: a systematic review | Q38055386 | ||
| TFOS DEWS II Diagnostic Methodology report | Q38652978 | ||
| TFOS DEWS II Epidemiology Report | Q38652994 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| TFOS DEWS II Introduction. | Q39453315 | ||
| Relevance of Lipid-Based Products in the Management of Dry Eye Disease | Q43119649 | ||
| Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film. | Q43325080 | ||
| Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study | Q44877483 | ||
| The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye. | Q46727604 | ||
| Comparison of treatment effect across varying severities of meibomian gland dropout | Q47605118 | ||
| Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye. | Q47738682 | ||
| Comparison of the effect of a hyaluronate-trehalose solution to hyaluronate alone on Ocular Surface Disease Index in patients with moderate to severe dry eye disease. | Q49582445 | ||
| New insights into the morphology and function of meibomian glands. | Q49816507 | ||
| Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment. | Q49976599 | ||
| Safety and Efficacy of an Artificial Tear Containing 0.3% Hyaluronic Acid in the Management of Moderate-to-Severe Dry Eye Disease. | Q50227023 | ||
| Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease. | Q50234908 | ||
| Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time. | Q50494570 | ||
| Clinical relationship of meibometry with ocular symptoms and tear film stability. | Q50520048 | ||
| Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease. | Q52643805 | ||
| Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview. | Q52679056 | ||
| Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. | Q53328538 | ||
| Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study. | Q53626973 | ||
| Saffron ( L.) in Ocular Diseases: A Narrative Review of the Existing Evidence from Clinical Studies | Q64081803 | ||
| Mucoadhesive properties of tamarind-seed polysaccharide/hyaluronic acid mixtures: A nuclear magnetic resonance spectroscopy investigation | Q85347097 | ||
| P433 | issue | 9 | |
| P921 | main subject | eye disease | Q3041498 |
| Meibomian gland dysfunction | Q110419412 | ||
| P304 | page(s) | 1368-1373 | |
| P577 | publication date | 2020-09-18 | |
| P1433 | published in | International Journal of Ophthalmology | Q26841911 |
| P1476 | title | Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction | |
| P478 | volume | 13 |
Search more.